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Purpose: To evaluate differences in prescription medication adherence rates,
as well as influencing factors, in rural and urban adults.
Methods: This is a retrospective analysis of the 2015 National Consumer Sur-
vey on the Medication Experience and Pharmacists’ Role. A total of 26,173
participants completed the survey and provided usable data. Participants us-
ing between 1 and 30 prescription medications and living more than 0 miles
and up to 200 miles from their nearest pharmacy were selected for the study,
resulting in a total of 15,933 participants. Data from the 2010 US Census and
Rural Health Research Center were used to determine the population density
of each participant’s ZIP code. Participant adherence to reported chronic med-
ications was measured based on the 8-item Morisky Medication Adherence
Scale (MMAS-8).
Findings: Overall adherence rates did not differ significantly between rural
and urban adults with average adherence based on MMAS-8 scores of 5.58
and 5.64, respectively (P = .253). Age, income, education, male sex, and white
race/ethnicity were associated with higher adherence rates. While the overall
adherence rates between urban and rural adults were not significantly differ-
ent, the factors that influenced adherence varied between age-specific popula-
tion density groupings.
Conclusion: These analyses suggest that there is no significant difference in
adherence between rural and urban populations; however, the factors con-
tributing to medication adherence may vary based on age and population den-
sity. Future adherence intervention methods should be designed with consid-
eration for these individualized factors.
Key words access to care, health care access, medication adherence, medi-
cation use, pharmacy.
Medication nonadherence is considered one of the great-
est modifiable health risks to exist in the United States.
Nearly half of all Americans who are prescribed a pre-
scription medication are nonadherent to it.1 The presence
of nonadherence to prescription medications causes poor
health-related outcomes. Nonadherence has been shown
to increase the likelihood of disease progression, lead to
higher utilization of health care services, increase the cost
of care, and cause higher mortality rates.2-9
The cause of nonadherence is complex and there
are many factors that have been linked to increasing
rates of nonadherence. These include factors related
to the cost of the medications, socioeconomic status,
and convenience.10-15 With increasing rates of poverty
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among those living in rural areas, overall lower median
household income for rural dwellers compared to ur-
ban dwellers, reduced rates of insurance coverage for ru-
ral dwellers, and increased distance to health care ser-
vices among individuals living in rural communities, one
would assume the risk of nonadherence is increased
among those living in rural communities.16-19
Nearly 50 million individuals are reported to live in ru-
ral settings across the United States.19 Research has con-
tinued to show that health-related outcomes are often
worse across chronic diseases for individuals living in ru-
ral settings.17,20 The cause of these poor outcomes is of-
ten the center of debate; however, some studies have
suggested that access to health care services and medi-
cations may contribute.17,21,22 There has been limited re-
search to assess differences in medication adherence in
rural and urban communities.23 As most chronic condi-
tions are currently treated through the use of chronic pre-
scription medications, it is important to evaluate if differ-
ences in the use of prescription medications exist between
rural and urban populations.
The objective of this study is to compare adherence
rates between rural and urban populations. Addition-
ally, the study evaluates differences between known




This study was a retrospective analysis of the 2015 Na-
tional Consumer Survey on the Medication Experience
and Pharmacists’ Role. The 2015 National Consumer Sur-
vey was conducted using Qualtrics Panels (Qualtrics LLC,
Provo, Utah) to provide participant panels and enroll par-
ticipants based on census statistics for geographic loca-
tion, age, and gender. Qualtrics Panels is an online sample
of study participants maintained by the online survey sys-
tem, Qualtrics. Participants were recruited online actively
by Qualtrics from this sample and results were provided
to researchers. All communications to potential partici-
pants were delivered electronically. Participation strati-
fication was included to ensure a minimum of 500 re-
spondents from each of the 50 states and the District of
Columbia. A total of 26,173 participants completed the
study and provided useable data.
Study Population
The study sample included US residents aged 18 years
and older at the time of completion. The data were col-
lected in 2015. The sample included all participants from
the original data set, but it was limited to those using
prescription medications. Data were restricted to include
those using between 1 and 30 prescription medications.
Additionally, participants with incomplete responses and
those reporting living over 200 miles from the nearest
pharmacy or living 0 miles from the nearest pharmacy
were excluded from the sample.
Variables
Adherence to reported chronic medications was mea-
sured based on the 8-item Morisky Medication Ad-
herence Scale (MMAS-8). The scale has been proven
to be a reliable and valid measure of patient-reported
adherence.24-26 The scoring of responses range from 0
(worse possible adherence score) to 8 (best possible ad-
herence score). The scores for participant MMAS-8 were
reported both as raw scores ranging from 0 to 8 and
grouped by level of adherence, with those scoring less
than 6 being defined as low adherers, those scoring 6 to
less than 8 defined as medium adherers, and those scor-
ing 8 as high adherers, as recommended.24
Participant-reported ZIP codes were compared to rural-
urban commuting area (RUCA) scores compiled by the
Rural Health Research Center to assign each participant’s
population density as rural, suburban, or urban. RUCA
scores classify US Census tracts using measures of popu-
lation density, urbanization, and daily commuting. The
latest version of RUCA scoring, based on 2010 Census
data, provides a cross-walk between ZIP codes and RUCA
score. Participants residing in a ZIP code with a RUCA
score of greater than 6 were defined as rural, those with
a RUCA score of between 2 and 6 were defined as subur-
ban, and those with a RUCA score of 1 were defined as
urban.
An abbreviated version of the Beliefs about Medicines
Questionnaire (BMQ) was used to gain participants’ per-
ception regarding the necessity of and concerns about
medications.27 Individual question responses were used
to establish participant harm, overuse, life-saving, and
burden belief. Composite scoring for the BMQ was not
used as the survey did not include the full BMQ ques-
tionnaire, which restricted scoring to responses to in-
dividual items. Participants rated agreement with in-
cluded statements based on a 7-point Likert scale. Based
upon the Concerns-Necessity Framework, necessity be-
liefs have previously been shown to be positively related
to medication adherence, while concerns, overuse be-
liefs, and harm beliefs have been shown to be negatively
related.28 Additionally, respondents were also asked to
rate their level of agreement using the same Likert scale
to the statement, “Purchasing medications causes me fi-
nancial hardship.” This served as the marker for financial
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hardship, with higher numerical values being associated
with greater levels of agreement that purchasing med-
ications cause financial hardship. Participants were also
asked to rate their overall health on a 4-point scale, rang-
ing from excellent to poor.
Analysis
Participant demographics and characteristics, medication
adherence, and population density of ZIP code were re-
ported using descriptive statistics. Multivariate regression
analyses were used to assess associations between med-
ication adherence (the dependent variable) and educa-
tion level, household income, medications causing fi-
nancial hardship, age, self-rated health score, distance
to the nearest pharmacy, use of mail order pharmacies,
use of the drive-through at their pharmacy, medication
burden belief, medication life-saving belief, medication
overuse belief, total number of prescription medications
taken daily, and medication harm belief (independent
variables). All independent variables were added to the
models at the same time. Education level, household in-
come, use of mail order pharmacies, and use of a drive-
through at the pharmacy were treated as categorical vari-
ables, with lowest level of education and lowest income
level serving as the reference level. As it was hypoth-
esized that the importance of these factors differed be-
tween rural, suburban, and urban participants, separate
models were constructed for each cohort. Additionally,
these cohorts were further deconstructed by age groups
because of the significant difference in age groupings be-
tween cohorts, and regression models were constructed
for each subset.
Software
All participants’ records were stored in a relational
database using the open-source database software
MySQL (v. 5.7.11, Oracle, Redwood Shores, California).
All analytics were performed using the open-source sta-
tistical computing software R (v 3.2.3, R Foundation,
Vienna, Austria).
Results
Of the 26,173 participants, 16,677 reported taking be-
tween 1 and 30 prescription medications. Of those taking
prescription medications, a total of 15,933 participants
met the additional inclusion criteria. Based on the 2010
RUCA designations, a total of 1,735 participants were ru-
ral dwellers, 5,302 were suburban dwellers, and 8,896 ur-
ban dwellers.
The demographic makeup of the 3 levels of popula-
tion density varied significantly, with individuals under
the age of 41 making up over 44% of the population for
urban centers while this same age group accounted for
only 35% of the population in rural areas. Conversely,
individuals over the age of 54 accounted for a larger pro-
portion of rural participants, with 44% of them living in
rural areas and 37% in urban areas. The difference in the
age distribution results in rural areas having an average
age of 49.1 years and urban areas having an average age
of 46.3 years (P < .005; Table 1).
Income distribution was similarly unevenly distributed
between the 3 subgroups. The percentage of individuals
with a household income of less than $40,000 per year
was greatest among rural participants, compared to sub-
urban and urban areas (54.9%, 46.2%, and 39.7%, re-
spectively). Differences also existed by educational status,
sex, and ethnicity. Table 1 provides further demographic
information about the participants contained within each
group. The overall mean adherence score based on the
MMAS-8 was 5.6 (SD = 2.0) for all participants. The
mean adherence score was compared for rural, suburban,
and urban participants, as was the proportion of partici-
pants meeting certain adherence criteria. There was no
significant difference between each of the groups based
on mean adherence scores (Table 2). Rurality groups had
roughly equivalent proportions of individuals classified
as low adherence (MMAS-8 < 6; rural 49.5%, suburban
50.3%, and urban 50.7%), medium adherence (MMAS-
8  6 and < 8; rural 27.5%, suburban 28.2%, and urban
28.3%) and high adherence (MMAS-8 = 8; rural 23.1%,
suburban 21.6%, and urban 21.0%; Table 2).
Based on subset analyses of each of the designations
according to population density, similar adherence scores
were also shown between rural, suburban, and urban
participants when categorized by other demographic fac-
tors. For instance, there were no statistically significant
differences in medication adherence scores between ru-
ral, urban, and suburban participants when comparing
the same age groups, income groups, education level, sex,
and ethnicity (Table 3).
A multivariable linear regression was constructed for
all participants, as well as separately for rural participants
and urban participants (Table 4). The results of the over-
all and separated rural versus urban regression models
showed similarities. However, some factors included in
the model had significance only in urban participants and
not rural participants, including distance to pharmacy
(B = −0.01, P < .001), use of mail order pharmacies (B =
−0.14, P = .002), and perceptions of medication-related
factors.
To better understand potential differences among var-
ious age groups of rural and urban dwellers, a series of
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Table 1 Demographics of Participants, Separated Based on Rural, Suburban, or Urban Dwelling
Variables Rural Suburban Urban Significancea
Total participants 1,735 (10.9%) 5,302 (33.28%) 8,896 (55.83%)
Mean age 49.1 47.9 46.3 <.005
Mean medication count 3.7 3.6 3.3 <.005
Age group
18-29 245 (14.1%) 872 (16.5%) 1,832 (20.6%) <.005
30-41 357 (20.6%) 1,131 (21.3%) 2,112 (23.7%) <.005
42-53 376 (21.7%) 1,155 (21.8%) 1,642 (18.5%) <.005
54-65 406 (23.4%) 1,118 (21.1%) 1,590 (17.9%) <.005
Over 65 351 (20.2%) 1,026 (19.4%) 1,720 (19.3%) .676
Income
Income at or below $40,000 953 (54.9%) 2,451 (46.2%) 3,528 (39.7%) <.005
Income between $41,000 and $100,000 658 (37.9%) 2,360 (44.5%) 4,193 (47.1%) <.005
Income over $100,000 124 (7.2%) 491 (9.3%) 1,175 (13.2%) <.005
Education
High school degree or less 521 (30.0%) 1,283 (24.2%) 1,673 (18.8%) <.005
Some college to bachelor’s degree 1,052 (60.6%) 3,463 (65.3%) 5,961 (67.0%) <.005
Advanced degree 162 (9.3%) 556 (10.5%) 1,262 (14.2%) <.005
Sex
Male 409 (23.6%) 1,374 (25.9%) 2,585 (29.1%) <.005
Female 1,326 (76.4%) 3,928 (74.1%) 6,311 (70.9%) <.005
Ethnicity
White 1,594 (91.9%) 4,681 (88.3%) 7,101 (79.8%) <.005
Non white 141 (8.1%) 621 (11.7%) 1,795 (20.2%) <.005
aSignificance reported as P values from chi-square difference test.
P< .05 considered significant.
Table 2 Adherence Rates within Rural, Urban, and Suburban Settings
Rural (N = 1,735) Suburban (N = 5,302) Urban (N = 8,896) Significance
Average MMAS-8 score (SD)a 5.64 (2.04) 5.64 (2.02) 5.58 (2.05) .253
Low adherence N (%)b 858 (49.5%) 2,664 (50.3%) 4,511 (50.7%) .604
Medium adherence N (%)b 477 (27.5%) 1,493 (28.2%) 2,514 (28.3%) .809
High adherence N (%)b 400 (23.1%) 1,145 (21.6%) 1,871 (21.0%) .162
aSignificance reported as P values from Kruskall–Wallis comparing differences between groups.
bSignificance reported as P values from chi-square difference test.
Use of theMMAS-8 is protected by US copyright laws. Permission for use is required. A license agreement is available fromDonald E. Morisky, 294 Lindura
Court, Las Vegas, NV 8,9138-4,632; dmorisky@gmail.com.
multivariable linear regression subset analyses were con-
ducted. The results for rural versus urban cohorts based
on age groupings (aged 18-41, 42-64, and 65+) can be
found in Table 5. According to the regression analysis,
factors that are significantly associated with adherence
varied dependent on population density and age group-
ings. Comparing urban and rural while holding age group
constant revealed differences and similarities between ru-
ral and urban participants. For instance, adherence of ru-
ral and urban participants aged 65 and older were both
impacted by financial hardship (P = .004, P < .001, re-
spectively) and perception of medication as a burden (P =
.010, P < .001, respectively); whereas only the adherence
for urban individuals over 65 years of age was impacted
by the use of drive-through pharmacies (P < .001), and
their overall health ranking (P < .001).
Discussion
Among all the different demographic factors, age had the
largest impact on adherence with those aged 18-29 re-
porting an average mean score of 4.85, while those aged
65 and over reported an average adherence score of 6.69,
with a higher score equating to better adherence. Ad-
ditionally, increased income, increased education level,
male sex, and white race/ethnicity are all associated with
increased adherence for all participants in this study.
4 The Journal of Rural Health 00 (2018) 1–8 c© 2018 The Authors The Journal of Rural Health published by Wiley Periodicals, Inc. on behalf of National Rural Health Association
Arbuckle et al. Medication Adherence in Rural, Urban, and Suburban
Table 3 Adherence Scores among Different Demographic Groups Based on Rural, Suburban, or Urban Dwelling
Variables Rural Suburban Urban Overall
Age Group Mean MMAS-8 Score (SD) Mean MMAS-8 Score (SD) Mean MMAS-8 Score (SD) Mean MMAS-8 Score (SD)
18-29 4.86 (2.07) 4.82 (2.12) 4.85 (2.07) 4.85 (2.09)
30-41 4.98 (2.21) 5.06 (2.09) 5.02 (2.12) 5.03 (2.12)
42-53 5.53 (1.99) 5.48 (1.98) 5.50 (2.04) 5.50 (2.01)
54-65 5.97 (1.87) 6.04 (1.78) 6.04 (1.81) 6.03 (1.81)
Over 65 6.59 (1.54) 6.70 (1.50) 6.70 (1.50) 6.69 (1.50)
Income
Income at or below $40,000 5.47 (2.10) 5.46 (2.07) 5.43 (2.08) 5.45 (2.08)
Income between $41,000 and $100,000 5.86 (1.96) 5.75 (1.98) 5.61 (2.04) 5.68 (2.02)
Income over $100,000 5.79 (1.88) 6.01 (1.85) 5.94 (1.92) 5.95 (1.90)
Education
High school degree or less 5.65 (2.05) 5.62 (2.05) 5.59 (2.05) 5.61 (2.05)
Some college to bachelor’s degree 5.61 (2.04) 5.61 (2.00) 5.54 (2.04) 5.57 (2.03)
Advanced degree 5.84 (1.99) 5.87 (2.00) 5.79 (2.08) 5.82 (2.05)
Sex
Male 5.85 (1.93) 5.90 (1.94) 5.69 (2.06) 5.77 (2.02)
Female 5.58 (2.07) 5.54 (2.04) 5.54 (2.04) 5.55 (2.04)
Ethnicity
White 5.71 (2.01) 5.72 (1.99) 5.72 (2.01) 5.72 (2.00)
Other 4.86 (2.23) 5.03 (2.14) 5.06 (2.13) 5.04 (2.14)
Initial interpretation of the data suggests that med-
ication use and adherence is the same between rural,
suburban, and urban individuals. This is, however,
complicated by the fact that participant demographics
and general characteristics are different between each of
these groups. Previous research has established positive
relationships with age and female sex with increased
adherence to prescription medications. With the rural
group of participants being significantly older and having
a larger proportion of females than suburban and urban
participants, one would assume that the rural group
would have increased adherence rates.29,30 This is, how-
ever, counterbalanced by the fact the rural participants
reported lower income levels and an increased distance
to the nearest pharmacy, which are associated with
lower levels of medication adherence.
Based on separate regression analyses for rural and ur-
ban participants, the demographic and belief factors im-
pacting adherence between rural and urban participants
vary (Tables 4 and 5). Adherence for rural participants
over the age of 65 was negatively influenced by financial
hardship of medications, whereas adherence for these
individuals was positively impacted by perceptions of
medication burden. Alternatively, adherence for urban
participants over the age of 65 was negatively impacted
by financial hardship, use of drive-through pharmacies,
and overall health ratings, but adherence was positively
affected by perceptions of medication burden.
Additionally, differences between factors that impact
adherence among different age groups of rural partici-
pants were shown. For instance, adherence for individu-
als aged 18-41 and 42-65 was impacted by overall health
score and use of drive-through pharmacies, while these
2 variables were not related to adherence of rural par-
ticipants older than 65. The differential relationship be-
tween self-rated health status and adherence based on
age of rural participants may suggest that younger rural
participants with worse perceived health place increased
importance on adhering to their medication.
Financial hardship was shown to negatively impact
adherence across all age groups, regardless of being
identified as urban or rural dwellers. Although this factor
impacts medication for participants from all population
densities, it was hypothesized that this would be of
greater importance for rural participants, considering the
higher levels of poverty and lower median household in-
comes reported in rural areas compared to urban areas.31
This was, however, not supported by the results of this
study, which suggested financial hardship was equally
impactful for urban and rural dwellers. It is important
to note that the negative correlation between financial
hardship and adherence should be interpreted as higher
levels of agreement that medications cause financial
hardship is associated with lower MMAS-8 scores, which
equates to worse adherence. Similarly, the use of a
drive-through at the pharmacy was associated with
worse adherence, hence, the negative beta coefficient
reported in Table 4. However, this study is not able to
determine if these relationships are causative in nature.
Additional research is needed to evaluate this further.
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Table 4 Linear Regression of MMAS-8 Scores in Total Participant Population and Separated by Urban and Rural Population Densities
All Participants All Rural Participants All Urban Participants
B∗ P B∗ P B∗ P
(Intercept) 4.17 <.001 4.17 <.001 4.27 <.001
Education levela −0.07 0.004 −0.09 0.269 −0.05 0.128
Household incomea 0.06 0.011 0.06 0.457 0.06 0.052
Financial hardshipb −0.16 <.001 −0.16 <.001 −0.16 <.001
Age 0.04 <.001 0.04 <.001 0.04 <.001
Overall health −0.43 <.001 −0.41 <.001 −0.45 <.001
Distance 0.00 0.106 0.00 0.062 −0.01 <.001
Mail order pharmacy usagec −0.08 0.019 −0.05 0.664 −0.14 0.002
Drive-through usagec −0.30 <.001 −0.35 <.001 −0.32 <.001
Burden 0.18 <.001 0.21 <.001 0.18 <.001
Life-saving 0.04 <.001 0.06 0.026 0.05 <.001
Overprescribed 0.05 <.001 0.07 0.064 0.05 <.001
Harm 0.10 <.001 0.04 0.298 0.09 <.001
Number of prescription medications −0.02 0.002 −0.04 0.016 −0.02 0.029
Observations 15,933 1,735 8,896
R2/adj. R2 .224/.223 .215/.209 .232/.231
∗Beta-coefficients reporting negative values indicate a negative association with adherence.
aEducation level and household income were input using categorical values, with lowest education level and lowest household income category serving
as the reference level.
bFinancial hardship was input as a continuous variable, with higher values relating to increased level of agreement of financial hardship caused by
medications.
cFactors reported categorically with no serving as the reference level.
Table 5 Subset Multilinear Regression Analysis for Rural and Urban Participants Based on Age Groups
Rural 18-41 Urban 18-41 Rural 42-65 Urban 42-65 Rural 65+ Urban 65+
B P B P B P B P B P B P
(Intercept) 5.26 <.001 5.58 <.001 6.43 <.001 5.93 <.001 6.29 <.001 6.53 <.001
Education level 0.04 .787 −0.01 .883 −0.30 .009 −0.10 .090 0.26 .050 0.03 .552
Household income 0.25 .098 0.13 .013 0.01 .950 0.07 .143 −0.20 .161 −0.02 .755
Financial hardship −0.18 <.001 −0.19 <.001 −0.18 <.001 −0.15 <.001 −0.15 .004 −0.12 <.001
Overall health −0.61 <.001 −0.52 <.001 −0.36 <.001 −0.43 <.001 −0.15 .272 −0.24 <.001
Distance 0.01 .081 −0.01 .002 0.01 .006 −0.01 .031 −0.01 .074 −0.01 .169
Mail order pharmacy usage −0.25 .317 −0.45 <.001 −0.08 .622 0.19 .014 0.13 .423 −0.08 .240
Drive−through usage −0.42 .014 −0.34 <.001 −0.39 .010 −0.30 <.001 −0.24 .276 −0.35 <.001
Burden 0.25 <.001 0.16 <.001 0.22 <.001 0.23 <.001 0.16 .010 0.17 <.001
Life-saving 0.09 .060 0.07 <.001 0.06 .161 0.03 .172 0.07 .245 0.05 .057
Overprescribed 0.08 .190 0.05 .074 0.07 .205 0.05 .056 −0.08 .295 0.06 .051
Harm −0.03 .646 0.09 <.001 0.05 .375 0.08 .005 0.14 .059 0.04 .216
Number of prescription medications −0.01 .819 −0.03 .030 −0.05 .037 0.01 .650 −0.06 .057 −0.03 .032
Observations 602 3,944 782 3,232 351 1,720
R2/adj. R2 .151/.134 .147/.144 .152/.139 .134/.130 .139/.109 .138/.132
Limitations
This study had a number of limitations that the authors
wish to describe. First, data collection was conducted
electronically, which requires individuals to have inter-
net and computer access to enroll in the study. This may
have been a limiting factor for both older populations
and those living in more rural areas. Second, the use
of a self-reported adherence scale, such as the MMAS-
8, does limit the researchers’ ability to verify the accu-
racy of the levels of adherence reported. The MMAS-8
has been widely used and validated, but self-reporting
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of adherence without incorporation of additional metrics
has potential limitations. Additionally, the data collected
only allowed researchers to report correlations between
individual factors and adherence. The nature of the data
collected does not allow researchers to determine if each
factor is causative in nature, which would require addi-
tional data collection. Last, it is important to note that
each subgroup did not contain the same number of re-
sponses.
Conclusion
The percentage of participants falling into the low adher-
ence category, approximately 50%, is similar between ru-
ral, urban, and suburban dwellers. This finding is similar
to previous research in medication adherence and is gen-
erally concerning. When comparing factors impacting ad-
herence between rural and urban individuals and those
of different age clusters, distinct overall factors influenc-
ing adherence were identified for each group. However,
many adherence interventions to date target a single vari-
able identified as a potential factor that impacts adher-
ence. Based on the results of this study, adherence in-
terventions should be further individualized, particularly
when considering population density and age.
Development of screening tools and targeted adher-
ence approaches may increase the success of such adher-
ence interventions. One factor that should be evaluated
among all participants is the impact of financial hardship
on medication use, as all participant groups had negative
associations between financial hardship and adherence.
Additionally, the use of the drive-through at local phar-
macies should be further reviewed, as the reported use of
such services was negatively associated with adherence
across all participant groups.
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